Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections

R Nau, F Sörgel, H Eiffert - Clinical microbiology reviews, 2010 - Am Soc Microbiol
The entry of anti-infectives into the central nervous system (CNS) depends on the
compartment studied, molecular size, electric charge, lipophilicity, plasma protein binding …

Antibacterial peptides for therapeutic use: obstacles and realistic outlook

AK Marr, WJ Gooderham, REW Hancock - Current opinion in pharmacology, 2006 - Elsevier
Cationic antimicrobial peptides are produced by almost all species of life as a component of
their immediate non-specific defense against infections. The assets of these peptides in …

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and …

C Liu, A Bayer, SE Cosgrove, RS Daum… - Clinical infectious …, 2011 - academic.oup.com
To clarify whether apoptosis is involved in the injury processes induced by autoantibody
against cardiac β1-adrenoceptor, we investigated the biological and apoptotic effects of …

Pathogenesis and pathophysiology of pneumococcal meningitis

BB Mook-Kanamori, M Geldhoff… - Clinical microbiology …, 2011 - Am Soc Microbiol
Pneumococcal meningitis continues to be associated with high rates of mortality and long-
term neurological sequelae. The most common route of infection starts by nasopharyngeal …

[PDF][PDF] Guía de tratamiento antimicrobiano de la infección por Staphylococcus aureus

P Llinares, J Barberán, M Montejo, M Salavert… - Rev Esp …, 2013 - researchgate.net
La creciente tasa de resistencia de Staphylococcus aureus a meticilina (SARM) observada
en la década de los años 90, generó importantes lineas de estudio de nuevos antibióticos …

Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections

JN Steenbergen, J Alder, GM Thorne… - Journal of antimicrobial …, 2005 - academic.oup.com
Infections caused by drug-resistant pathogens are on the rise. Daptomycin, a cyclic
lipopeptide with activity against most Gram-positive pathogens, including vancomycin …

Bactericidal agents in the treatment of MRSA infections—the potential role of daptomycin

GL French - Journal of Antimicrobial Chemotherapy, 2006 - academic.oup.com
Over the last decade, methicillin-resistant Staphylococcus aureus (MRSA) strains have
emerged as serious pathogens. These strains are often multiresistant to several antibiotic …

Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact

JA Silverman, LI Mortin, ADG VanPraagh… - Journal of Infectious …, 2005 - academic.oup.com
The lipopeptide daptomycin has been approved for use in skin and skin-structure infections
but has failed to meet statistical noninferiority criteria in a clinical trial for severe community …

Natural products to drugs: daptomycin and related lipopeptide antibiotics

RH Baltz, V Miao, SK Wrigley - Natural product reports, 2005 - pubs.rsc.org
Covering: 1953 to September 2005Daptomycin (Cubicin®) is a lipopeptide antibiotic
approved in the USA in 2003 for the treatment of skin and skin structure infections caused by …

Chemoenzymatic approaches for exploring structure–activity relationship studies of bioactive natural products

F Li, H Deng, H Renata - Nature Synthesis, 2023 - nature.com
Spurred by advancements in microbial genetics and enzyme engineering, chemoenzymatic
strategies, which combine enzymatic and synthetic transformations, have increasingly made …